|
Key
Features: |
|
| Title and year of the Document | Guidelines for authors and peer reviewers of economic submissions to the British Medical Journal, 1996 |
| Affiliation of authors | Academia |
| Main policy objective | For authors and peer reviewers of economic submissions to the British Medical Journal |
| Standard reporting format included | Ten sections under three headings: study design, data collection, and analysis and interpretation of results |
| Disclosure | Not stated |
| Target audience of funding/ author’s interests | Authors and peer reviewers of economic evaluation |
| Perspective | Advocate: societal. |
| Indication | Emphasis on research question |
| Target population | Not stated |
| Subgroup analysis | Not stated |
| Choice of comparator | Most widely used. Most cost-effective currently available |
| Time horizon | Long enough to capture all the differential effects of the options. |
| Assumptions required | Yes |
| Preferred analytical technique | Any one of CMA, CCA, CEA, CUA, CBA |
| Costs to be included | Depends on the viewpoint chosen |
| Source of costs | From finance department of particular institution or from national statistics |
| Modeling | Yes, requires details |
| Systematic review of evidences | Yes |
| Preference for effectiveness over efficacy | Yes |
| Preferred outcome measure | Details should be given of the methods used |
| Preferred method to derive utility | Details should be given of the methods used |
| Equity issues stated | Not stated |
| Discounting costs | Yes, Between 3~6%, commonly 5% |
| Discounting outcomes | 0% or one lower than that used for costs, keep transparency |
| Sensitivity analysis-parameters and range | Uncertain variables from population, use CI; others, use threshold analysis, analysis of extremes. |
| Sensitivity analysis-methods | One-way, multi-way SA, probabilistic SA. |
| Presenting results | Major outcomes (direct costs, indirect costs, life years gained, improvement of quality of life) should be presented in a disaggregated form before being combined in an aggregated form (a single index or ratio). |
| Incremental analysis | Yes |
| Total C/E | Yes |
| Portability of results (Generalizability) | Generalizability is important |
| Financial impact analysis | No |
| Mandatory or recommended or voluntary | |
